💡 Vanqua Bio extends their Series B financing raising an additional $45M in funding! #neurodegenerativedisease
SJLife Sciences’ Post
More Relevant Posts
-
Early Bird rates for Bio€quity Europe ends Friday - register now to save! With 60+ biotechs already confirmed to present, this year’s event in San Sebastián is expected to sell out, again. In fact, we are on track to exceed last year, when 300 VCs, 330 CEOs, and 150 C-level executives joined. This year we will gather in Basque Country to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. I hope you will join BioCentury Inc., EBD Group, and Regional Host Committee Chair Ysios Capital in one of the culinary capitals of the world. Register for #BioEquityEurope by Friday to save: https://ow.ly/lkOl50QyYeS Learn more, including the schedule-at-a-glance and presenting companies you will meet: https://ow.ly/8B5c50QyYeR #biotech #biopharma
To view or add a comment, sign in
-
Join our Syneos Health Consulting team at JPM's Biotech Showcase next week in this panel discussion to learn more about how to invest for success in today's challenging environment!
Please join me at JPM's Biotech Showcase next week to learn more about how to invest for success in today's challenging environment! We will have four esteemed panelists sharing their experience: Aziz Mottiwala Bruce Seeley Rachelle Jacques Julie Miller Everett We will be in Franciscan Room A at the Hilton #SyneosHealth #biotech #JPM2024 #BiotechShowcase
To view or add a comment, sign in
-
We were proud to be selected as one of the Fierce Biotech Fierce 15 2024 Honorees. We asked ourselves – what makes us fierce? Here is what our team said #2. We have resilience of spirit: When we hit a stumbling block, our ingenuity helps us remain agile and allows us to find new ways towards our goals. In the spirit of continuous learning and improvement, we accept that not everything will work first time, and we learn from any failures. Read more about how OMassians are transforming lives together, our values and our team HERE: https://lnkd.in/ddaju6xf #innovation #biotech #drugdiscovery
To view or add a comment, sign in
-
We were proud to be selected as one of the Fierce Biotech Fierce 15 2024 Honorees. We asked ourselves – what makes us fierce? Here is what our team said #5. We are responsible: We take personal and collective responsibility for delivering our shared goals. We hold ourselves and each other accountable – to our patients, colleagues, investors, as well as our work and mission. We apply the necessary rigor to ensure high quality. We are self-motivated and rely on each other to operate and perform at the highest levels. Read more about how OMassians are transforming lives together, our values and our team HERE: https://lnkd.in/ddaju6xf #innovation #biotech #drugdiscovery
To view or add a comment, sign in
-
For #cellandgenetherapy and #orphandrugs Biotechs looking for investment, the challenges of 2023 are now behind us 👏 In 2024 the ongoing economic challenges that are preventing early stage #atmp and #orphandrug biotechs from securing the important funding they need to survive and progress means that our completely unique risk-sharing model is becoming more needed than ever to ensure the optimal chances of #fundraisingsuccess for our partners and clients. Thanks to Mark Beards, Damian Marron, Miguel Forte, Michèle Bartouilh-Neugebauer, Sonya M., Ian Hollingsworth and all those that have supported and advocated for our weird but wonderful, risky but required, frightening but fun business model for helping us to design and build what we know will be a hugely impactful service to our sector throughout 2024. We look forward to making a real difference to patients and shareholders alike during the coming year by supporting the #biotechnology organisations working hard to provide innovative therapies to our community. Wishing everyone in the #cellandgenetherapies and #rarediseases communities the very best for the year ahead!
To view or add a comment, sign in
-
Excited to share McKinsey’s latest report on the European biotech financing landscape based on our presentation at Bio€quity Europe 2024 a few weeks back. My key takeaway from the report? The biotech industry started 2024 with some positive trends on financing and these trends are bringing a sentiment of cautious optimism to both biotech companies and investors. Check out the infographic below for other key takeaways and read the report for more strategic implications and insights for investors and biotech companies alike: https://lnkd.in/e8mb-m9i #Biotech #BiotechInvestments #FutureOfBiotech #BioEquity
To view or add a comment, sign in
-
Excited to share McKinsey’s latest report on the European biotech financing landscape based on our presentation at Bio€quity Europe 2024 a few weeks back. My key takeaway from the report? The biotech industry started 2024 with some positive trends on financing and these trends are bringing a sentiment of cautious optimism to both biotech companies and investors. Check out the infographic below for other key takeaways and read the report for more strategic implications and insights for investors and biotech companies alike: https://lnkd.in/ey-YdTEa #Biotech #BiotechInvestments #FutureOfBiotech #BioEquity
To view or add a comment, sign in
-
The final results of our #BIO2024 step competition are in. Technically, there is one more day of BIO, but we limited the competition to the three "heavy days". Jessica Davis wins bragging rights with over 50K steps (~21 miles) walked and sometimes ran during the show. Her victory embodies one of the pillars of Dynamk Capital's investment strategy - CONSISTENCY! A key message we heard this week at BIO was that companies are indeed seeing positive growth indicators. Those who circled the wagons the past 12-18 months and focused on their core business, like Dyanmk Capital's portfolio companies, are poised to capitalize in 2024. A special thanks to our partners who co-exhibited this year at BIO: CellFE RoosterBio Inc. Vernal Biosciences Virica Biotech #venturecapital #biomanufacturing #drugdiscovery #cellandgenemanufacturing
To view or add a comment, sign in
-
We were proud to be selected as one of the Fierce Biotech Fierce 15 2024 Honorees. We asked ourselves – what makes us fierce? Here is what our team said #7. We are caring: People at OMass care about each other as individuals, respecting and embracing our diverse experiences, backgrounds and perspectives. Really getting to know each other helps us feel connected and included. We are unselfish, appreciate each other and take time to help and support one another. Caring is a 360° thing, where team members care about each other, the company cares about us, and we care about the company. Read more about how OMassians are transforming lives together, our values and our team HERE: https://lnkd.in/ddaju6xf #innovation #biotech #drugdiscovery
To view or add a comment, sign in
-
Bio Innovations Midwest is only 2 months away, the event is based on the successful World Bio Markets held in Europe. Taking place on September 24-25 in Omaha, NE, Bio Innovations Midwest provides the same 1-2-1 commercial meetings that World Bio Markets offers. Now coming to the US as Bio Innovations Midwest, this conference will facilitate networking and knowledge exchange better connecting bio pioneers in the US and abroad with international brands from all points in the value chain. Some German businesses partaking in the first Bio Innovations Midwest includes Evonik, Helm AG, AMSilk. Benoit Cugnet, Head of Fiber Business at AMSilk GmbH | Biotech Materials said the following about their experiences at World Bio Markets and provide a good comparison of what to expect for Bio Innvoations Midwest. For more information, sponsorship, and registration - https://lnkd.in/eE63_gQN #Sponsored #BIMW24 #bioindustry #biomanufacturing #biobased #biorevolution #circulareconomy #sustainability #WBM #WorldBioMarkets #NebraskaBio World Bio Markets & Bio Innovations Midwest
To view or add a comment, sign in
626 followers